<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01981746</url>
  </required_header>
  <id_info>
    <org_study_id>SM2-PJ-13</org_study_id>
    <nct_id>NCT01981746</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers</brief_title>
  <official_title>Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether reducing the volume (30 versus 10 ml) ropivacaine injected can reduce
      the number of subjects with impaired muscle strength following adductor canal block. We
      hypothesized that adductor canal block with 10 ml 0.1% ropivacaine preserves quadriceps
      strength compared with an adductor canal block with 30 ml.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with reduced quadriceps strength</measure>
    <time_frame>0.5 to 6 hours post block</time_frame>
    <description>The difference between the two volumes in number of subjects experiencing a reduction in quadriceps muscle strength by more than 25% from baseline in two consecutive assessments.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quadriceps strength in percentage of baseline</measure>
    <time_frame>2, 3 and 4 hours post block</time_frame>
    <description>The difference between the two volumes in maximum voluntary isometric contraction (MVIC) of the quadriceps muscle, assessed as percentage of the baseline value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps strength calculated as AUC</measure>
    <time_frame>30 minutes to 6 hours post block</time_frame>
    <description>The difference between the two volumes in maximum voluntary isometric contraction (MVIC) of the quadriceps muscle calculated as &quot;area under the curve&quot; (AUC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified 30-second Chair Stand test</measure>
    <time_frame>2 and 4 hours post block</time_frame>
    <description>The difference between the pre block value and the post block value in the modified 30-second Chair Stand test performed on one leg, between the two volumes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS pain scores during warmth stimulation</measure>
    <time_frame>Mean value for the periode 30 minutes - 6 hours post block</time_frame>
    <description>The difference between the two volumes in VAS pain score during warmth stimulation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Muscle Strength</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>30 ml</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 ml ropivacaine 0.1%, single bolus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 ml</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 ml 0.1% ropivacaine, single bolus</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor canal block with ropivacaine 0.1%</intervention_name>
    <description>US-guided adductor canal block</description>
    <arm_group_label>30 ml</arm_group_label>
    <arm_group_label>10 ml</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-30 years

          -  Men

          -  ASA 1

          -  Body Mass Index 18-25

        Exclusion Criteria:

          -  Allergy to study medication

          -  Earlier trauma or surgery to the lower limb

          -  Diabetes Mellitus
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pia Jaeger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2013</study_first_submitted>
  <study_first_submitted_qc>November 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2013</study_first_posted>
  <last_update_submitted>January 9, 2014</last_update_submitted>
  <last_update_submitted_qc>January 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Pia Jaeger</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>adductor canal block</keyword>
  <keyword>healthy volunteers</keyword>
  <keyword>US-guided peripheral nerve block</keyword>
  <keyword>lower limb</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

